Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New malaria vaccine described in patent literature

March 16, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Alliance formed for development of oral vaccines from plants

March 11, 1998

PGG-glucan displays potent protective effects in guinea pig model

March 10, 1998

PowderJect and Glaxo Wellcome enter DNA vaccine collaboration

March 10, 1998

Boston Life Sciences licenses BCLx-gamma gene from Harvard

March 10, 1998

Zenapax approved in Switzerland

March 5, 1998

Vaccines for group B meningococcal infection disclosed

March 4, 1998

Cholera toxin enhances transcutaneous delivery, enabling development of needle-free vaccines

March 4, 1998

NIH offers potential tuberculosis vaccine technology for licensing

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...